Scholar Rock Holding Corporation —— 财务报表 (NASDAQ:SRRK) | MetaTrader

展开完整图表

新闻

SRRK Stock Jumps on Resubmission of FDA Filing for SMA Drug

Scholar Rock Holding Corporation (SRRK) Discusses BLA Resubmission for Apitegromab in Spinal Muscular Atrophy and Regulatory Progress Transcript

Scholar Rock: From Manufacturing Hurdle To Commercial Muscle, Maintaining Buy Rating (NASDAQ:SRRK)

摩根大通上调Scholar Rock目标价,看好药物获批前景

JPMorgan raises Scholar Rock stock price target on drug approval outlook

Scholar Rock在Leerink会议上发言:FDA延迟下的战略路径

Scholar Rock at Leerink Conference: Strategic Path Amid FDA Delays

Piper Sandler上调Scholar Rock目标价,看好SMA药物上市

Piper Sandler raises Scholar Rock stock price target on SMA launch

Barclays因债务协议将Scholar Rock目标价上调至53美元

Barclays raises Scholar Rock stock price target to $53 on debt deal

Truist因生产进展上调Scholar Rock目标价